Patent · US Active

Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof

US11285206B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

INSTITUTE OF ANIMAL HUSBANDRY AND VETERINARY SCIENCES, HUBEI ACADEMY OF AGRICULTURAL SCIENCES · CN

Inventors

Guoyuan Wen · 红钢城街道, CN
Li Li · Stanford, US
Yu-Ming Shang · Beijing, CN
Huabin Shao · Shanghai, CN
Qingping Luo · Beijing, CN
Honglin Wang · Hikone, JP
Ling Luo · Hangzhou City, CN
Rongrong Zhang · Zhejiang, CN
Hongcai Wang · 红钢城街道, CN
Tengfei Zhang · Zhenjiang, CN
Wenting Zhang · Tangxia, CN
Qin Lu · Guangxi, CN

Key dates

Filing date	Apr 20, 2021
Grant date	Mar 29, 2022
Priority date	—
Expiry date	Apr 20, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A heat-resistant recombinant Newcastle Disease Virus vaccine strain rLS-tFib2-C capable of expressing truncated Fiber 2 protein of fowl adenovirus serotype 4 has been preserved at the China Center for Type Culture Collection, Wuhan University, Wuhan, China with the preservation number of CCTCC No. V202042.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.